Covid-19 and Sars-CoV-2 Vaccines

Headache is a very frequent symptom in COVID-19 and SARS-CoV-2 vaccination. Many studies have emphasized its clinical diagnostic and prognostic importance on the one hand, as in many cases these aspects have been completely ignored. It is therefore opportune to go back over these lines of research in order to gather what usefulness the headache symptom may or may not represent for the clinician dealing with COVID-19 or performing or following up on the clinical course following vaccination for SARS-CoV-2. The clinical evaluation of headache in COVID-19 is not fundamental in the diagnostic and prognostic process of the emergency departments; however, the risk of severe adverse events, although very rare, must be taken into account by the clinicians. For subjects presenting with severe, drug-resistant, and delayed-onset post-vaccination headache, it could represent a possible sign of central venous thrombosis or other thrombotic complications. Thus, a re-reading of the role of headache in COVID-19 and SARS-CoV-2 vaccination seems clinically useful

2019-20 coronavirus outbreak · Adverse effect · Coronavirus disease 2019 (COVID-19 · Disease · Intensive care medicine · Pathology · Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 · Vaccination · Long-Term Effects of COVID-19 · Medicine · Retinal and Optic Conditions · SARS-CoV-2 and COVID-19 Research · Immunology · Internal Medicine · Pediatrics